Ticker Scorecard - ANRO Basics Company: Alto Neuroscience Inc. IPO Date: February 2, 2024 Sector: Healthcare Industry: Biotech Market Cap: $86.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.42 | 3.93% Avg Daily Range (30 D): $0.15 | 3.58% Avg Daily Range (90 D): $0.19 | 3.63% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .52M Trade Size Avg Trade Size (Sh.): 104 Avg Trade Size (Sh.) (30 D): 122 Avg Trade Size (Sh.) (90 D): 136 Institutional Trades Total Inst.Trades: 62 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $.74M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.53M Avg Closing Trade (30 D): $.64M Avg Closing Trade (90 D): $.65M Avg Closing Volume: 268.95K     News Oct 30, 2024 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossm... Source: Bronstein, Gewirtz & Grossman, Llc Apr 23, 2024 @ 6:55 PM Treatment Patch For Schizophrenia: Newly Listed Al... Source: Vandana Singh Apr 9, 2024 @ 1:37 PM Alto Neuroscience (ANRO): Strong Industry, Solid E... Source: Zacks Equity Research Feb 9, 2024 @ 9:29 PM Wall Street hungry for IPO of Mexican supermarket ... Source: MarketWatch Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.62 $-.6 Diluted EPS $-.62 $-.6 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -16.78M $ -16.03M Operating Income / Loss $ $ -18.89M $ -18.34M Cost of Revenue $ $ $ Net Cash Flow $ $ -11.42M $ -12.27M PE Ratio